Induced Pluripotent Stem Cells Derived from a CLN5 Patient Manifest Phenotypic Characteristics of Neuronal Ceroid Lipofuscinoses

Show simple item record

dc.contributor.author Uusi-Rauva, Kristiina
dc.contributor.author Blom, Tea
dc.contributor.author von Schantz-Fant, Carina
dc.contributor.author Blom, Tomas
dc.contributor.author Jalanko, Anu
dc.contributor.author Kyttala, Aija
dc.date.accessioned 2017-07-24T06:49:01Z
dc.date.available 2017-07-24T06:49:01Z
dc.date.issued 2017-05
dc.identifier.citation Uusi-Rauva , K , Blom , T , von Schantz-Fant , C , Blom , T , Jalanko , A & Kyttala , A 2017 , ' Induced Pluripotent Stem Cells Derived from a CLN5 Patient Manifest Phenotypic Characteristics of Neuronal Ceroid Lipofuscinoses ' , International Journal of Molecular Sciences , vol. 18 , no. 5 , 955 . https://doi.org/10.3390/ijms18050955
dc.identifier.other PURE: 87332103
dc.identifier.other PURE UUID: 7cdef92a-6ad2-4911-ba21-1217fa6a3704
dc.identifier.other WOS: 000404113900062
dc.identifier.other Scopus: 85018416661
dc.identifier.uri http://hdl.handle.net/10138/203371
dc.description.abstract Neuronal ceroid lipofuscinoses (NCLs) are autosomal recessive progressive encephalopathies caused by mutations in at least 14 different genes. Despite extensive studies performed in different NCL animal models, the molecular mechanisms underlying neurodegeneration in NCLs remain poorly understood. To model NCL in human cells, we generated induced pluripotent stem cells (iPSCs) by reprogramming skin fibroblasts from a patient with CLN5 (ceroid lipofuscinosis, neuronal, 5) disease, the late infantile variant form of NCL. These CLN5 patient-derived iPSCs (CLN5Y392X iPSCs) harbouring the most common CLN5 mutation, c.1175_1176delAT (p.Tyr392X), were further differentiated into neural lineage cells, the most affected cell type in NCLs. The CLN5Y392X iPSC-derived neural lineage cells showed accumulation of autofluorescent storage material and subunit C of the mitochondrial ATP synthase, both representing the hallmarks of many forms of NCLs, including CLN5 disease. In addition, we detected abnormalities in the intracellular organelles and aberrations in neuronal sphingolipid transportation, verifying the previous findings obtained from Cln5-deficient mouse macrophages. Therefore, patient-derived iPSCs provide a suitable model to study the mechanisms of NCL diseases. en
dc.format.extent 14
dc.language.iso eng
dc.relation.ispartof International Journal of Molecular Sciences
dc.rights cc_by
dc.rights.uri info:eu-repo/semantics/openAccess
dc.subject CLN5
dc.subject iPS cells
dc.subject NCL
dc.subject sphingolipid
dc.subject lysosomal storage disease
dc.subject JANSKY-BIELSCHOWSKY DISEASE
dc.subject HUMAN NEUROBLASTOMA-CELLS
dc.subject LATE INFANTILE NCL
dc.subject BATTEN-DISEASE
dc.subject CHOLESTEROL-METABOLISM
dc.subject ATP SYNTHASE
dc.subject PROTEIN
dc.subject VARIANT
dc.subject ACTIVATION
dc.subject MUTATIONS
dc.subject 3111 Biomedicine
dc.title Induced Pluripotent Stem Cells Derived from a CLN5 Patient Manifest Phenotypic Characteristics of Neuronal Ceroid Lipofuscinoses en
dc.type Article
dc.contributor.organization Department of Medical and Clinical Genetics
dc.contributor.organization University of Helsinki
dc.contributor.organization Medicum
dc.contributor.organization Institute for Molecular Medicine Finland
dc.contributor.organization Department of Anatomy
dc.description.reviewstatus Peer reviewed
dc.relation.doi https://doi.org/10.3390/ijms18050955
dc.relation.issn 1422-0067
dc.rights.accesslevel openAccess
dc.type.version publishedVersion

Files in this item

Total number of downloads: Loading...

Files Size Format View
ijms_18_00955_v2.pdf 3.711Mb PDF View/Open

This item appears in the following Collection(s)

Show simple item record